Navigation Links
Boston College's Amir Hoveyda receives Italy's Eni Award for Hydrocarbons Research
Date:6/17/2014

Chestnut Hill, Mass. (June 17, 2014) Boston College Professor of Chemistry Amir Hoveyda has received a 2014 Eni Award for New Frontiers in Hydrocarbons from an international panel of preeminent scientists assembled by the Enrico Mattei Foundation of the Italian energy giant Eni SpA.

Hoveyda and other leading researchers were honored June 17 at a ceremony in Rome, hosted by Italian President Giorgio Napolitano in the official presidential palace, the historic Quirinale. Hoveyda received a gold medal struck at the Italian State Mint and a cash award of $270,000 (US). The Eni Awards recognize leading researchers in the areas of energy and sustainable chemistry, part of an effort to promote innovation in energy use and research by Eni, which employs 82,300 people in 85 countries.

"I am humbled," said Hoveyda, the Joseph T. and Patricia Vanderslice Millennium Professor of Chemistry and a 24-year faculty member at BC. "This is further testimony to the dedication, creativity and industriousness of more 100 selfless doctoral, post-doctoral and undergraduate scholars who have asked and addressed scientific questions in my laboratories since 1990 at Merkert Chemistry Center. This is first and foremost applause for their accomplishments."

Hoveyda was honored in the "downstream" category for transformations of hydrocarbons drawn from raw materials. Hoveyda develops new catalysts for chemical synthesis that are sustainable, easy and cost-effective to access, and able to generate valuable products of exceptional purity with high efficiency - characteristics critical to advances in the life sciences and medicine.

Hoveyda joins an illustrious group of scientists who have receive the Eni, including Nobel laureate Sir Harold Kroto of the University of Sussex, and US researchers including MIT's Gregory Stephanopoulos, U.C. Berkeley's Enrique Iglesia, Cal Tech's Frances H. Arnold and Craig Venter of the Institute for Genomic Research.

The 2014 Eni Scientific Award Commission cited Hoveyda's development of catalysts capable of synthesizing complex molecules with unique steric properties, or specifically distinct spatial arrangements of their main chain atoms. Hoveyda catalysts produce high purity compounds used in pharmaceuticals, fine chemicals and agrochemicals, with applications that extend into advanced materials and polymers. Some of the catalysts are being used in large-scale preparation of hydrocarbon-based therapeutics.

The connections to energy lie in the development of exceptionally efficient catalysts with high turnover ratios in a short amount of time, involving the use of non-precious and abundant elements that convert readily available renewable materials into highly valued molecules humans rely upon.

"Such catalysts do not demand heating or cooling, or the energy required to promote such reactions," Hoveyda said. "They do not require expending our non-renewable resources, which demand substantial time and energy to mine, and generate minimal amounts of environmentally harmful waste and reduce the energy costs of disposal. Catalysts and catalytic chemical reactions that depend on renewable resources and abundant elements are, without a doubt, a critical part of our future."

Sobell Professor of Chemistry Ilan Marek, of the Technion Israel Institute of Technology, said Hoveyda's work has had far-reaching implications within the field of hydrocarbons.

"I would be hard pressed to identify another individual whose contributions to the field of catalysis involving carbon-carbon bonds match Amir's in terms of quality and quantity," said Marek. "Throughout his career, Amir's work has been characterized by remarkable originality and far-sightedness. He has been a central figure in the definition of major fields as we known them asymmetric catalysis, metathesis, and carbenes to name a few. In each case, the field was revolutionized by his work."

Hoveyda has been ranked among the world's Top 100 Chemists by Thomson Reuters. Among his honors are the 2014 American Chemical Society Award for Creative Work in Synthetic Organic Chemistry, the 2010 Yamada-Koga Prize from the Chemical Society of Japan and a 2005 National Institutes of Health MERIT Award, an honorific 10-year grant. He is co-founder of the life sciences firm XiMo AG, which commercializes catalysts discovered in the Hoveyda lab.

Hoveyda said his work supports other scientists, and ultimately serves patients treated with new therapeutics, and is intended to provide some measure of relief for an already overburdened planet.

"My hope is that our catalysts, many of which are already widely used all over the world in academic as well as industrial labs, will play a meaningful role in lowering suffering and pain, will help protect this beautiful planet that has been so badly abused by us humans," Hoveyda said. "I hope that our catalysts and methods of performing new chemical reactions will improve the quality of life for all living creatures without endangering our magnificent planet or having to mortgage the happiness of the future generations."


'/>"/>

Contact: Ed Hayward
ed.hayward@bc.edu
617-552-4826
Boston College
Source:Eurekalert  

Related biology news :

1. Boston Police Chief to Address Boston Marathon Bombings at IEEE Homeland Security Conference in Waltham, Mass., on 12 November
2. New findings on tree nuts and health presented at the Experimental Biology Meeting in Boston, Mass.
3. NIH grant funds Boston College research into illnesses afflicting people living with HIV
4. Michael Barnett of Boston College named Professor of the Year for Massachusetts
5. Synthetic biofilter wins through to the top Sweet 16 in Boston
6. Boston subway system to be used to test new sensors for biological agents
7. BUSM/VA Boston Healthcare System investigators identify new gene linked to PTSD
8. Boston Healthcare Associates Roundtable Explores Challenges and Opportunities Surrounding the Value of Big Data within the Life Sciences
9. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
10. Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012
11. Partnership enhances biology teaching at California community colleges
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Boston College's Amir Hoveyda receives Italy's Eni Award for Hydrocarbons Research
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology: